Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition


View by channel
 

View all webcasts/CME by date

Haematology Other

      mm/dd/yyyy
11/18/2009Evolving Strategies for Chronic Idiopathic Thrombocytepenic Purpura
11/11/2009PreAnesthetic Assessment of the Patient on Low Dose Aspirin and a Thienopyridine - Part 2
11/04/2009PreAnesthetic Assessment of the Patient on Low Dose Aspirin and a Thienopyridine - Part 1
09/21/2009Managing Treatment- and Disease-Related Complications in Multiple Myeloma
09/21/2009Thrombosis in Multiple Myeloma: Choice of Thromboprophylaxis Depends on Type of Therapy and Individual Risk of Patient
09/21/2009Peripheral Neuropathy in Multiple Myeloma: Early Recognition and Intervention Key to Minimize Long-Term Complications
09/21/2009Myeloma Bone Disease: Is Targeting of Osteoclastic and Osteoblastic Mechanisms Necessary for Effective Therapy?
08/17/2009Questioning Clinical Assumptions in Accelerated-Phase and Blast-Crisis CML
08/17/2009How Can We Clarify Treatment Approaches in High-Risk CML?
08/17/2009How Can We Improve Treatment & Outcome in Blast-Crisis CML?
07/16/2009Achieving Optimal Management of High-Risk CLL
07/16/2009Selecting Treatment for an Adult Male Patient With CLL and High-Risk Cytogenetic Features
07/16/2009Managing an Elderly Male Patient With CLL Failing Initial Therapy
07/06/2009Treatment Options For Chronic Immune Thrombocytopenic Purpura
07/02/2009State of the Science in Multiple Myeloma: Which New Therapies Have Convincingly Demonstrated Improvements in Efficacy?
07/02/2009Assessing the Benefits of Novel Therapies in Newly Diagnosed Multiple Myeloma: Clinical and Research Implications of the Latest Trials
07/02/2009Assessing the Benefits of Novel Therapies in Relapsed/Refractory Multiple Myeloma: Clinical and Research Implications of Latest Trials
06/26/2009State of the Art in Managing Anemia in Chronic Kidney Disease
06/26/2009Current Challenges in Managing CKD-Related Anemia
06/26/2009Optimizing Hemoglobin in CKD-Related Anemia
06/12/2009Understanding the Basics of Tumor Lysis Syndrome
06/09/2009Tailoring Supportive Care to Improve Patient Outcomes and Quality of Life: Update on Four Complications of Cancer
06/08/2009Acute Care Update: Causes, Consequences, and Strategies for Managing Critical Bleeding
06/03/2009Confronting the Challenges of Anticoagulation Therapy: New and Emerging Research
05/22/2009Optimizing Bone Health Management in Multiple Myeloma
05/22/2009Understanding the Development of Myeloma Bone Disease and Novel Targets for Therapy
05/22/2009Interpreting New Data on Established and Emerging Therapies for Improving Bone Health in Multiple Myeloma
05/19/2009Artifactual Laboratory Abnormalities in Patients with Paraproteinemia
05/14/2009Applying Key Biomarkers in Oncology: From Biospecimen Preparation and Storage to Clinical Implications
05/13/2009Evaluating Innovative Strategies in Relapsed/Refractory Mantle-Cell Lymphoma



         More webcasts/CME>>>




All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.